S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

ATXI Avenue Therapeutics Inc

4.75

-0.26 (-5.19%)

02 May 2024 - Closed

Delayed by 15 minutes

Avenue Therapeutics gets FDA panel's rejection on IV pain drug

To read the full story on Seeking Alpha, click here.

Avenue Therapeutics (NASDAQ:ATXI)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Avenue Therapeutics Charts.

Avenue Therapeutics (NASDAQ:ATXI)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Avenue Therapeutics Charts.

Avenue Therapeutics Inc News

Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
Monday 29 April 2024 (3 days ago) • GlobeNewswire Inc.

Avenue Therapeutics Announces Reverse Stock Split
Wednesday 24 April 2024 (1 week ago) • GlobeNewswire Inc.

Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024
Monday 25 March 2024 (1 month ago) • GlobeNewswire Inc.

Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights
Tuesday 19 March 2024 (1 month ago) • GlobeNewswire Inc.

Avenue Therapeutics Receives Positive Listing Determination from Nasdaq
Friday 15 March 2024 (2 months ago) • GlobeNewswire Inc.

Avenue Therapeutics to Present BAER-101 Preclinical Data at American Society for Experimental Neurotherapeutics (ASENT) 2024 Annual Meeting
Monday 11 March 2024 (2 months ago) • GlobeNewswire Inc.

Form PRE 14C - Other preliminary information statements
Saturday 9 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Saturday 9 March 2024 (2 months ago) • Edgar (US Regulatory)

Avenue Therapeutics Announces Publication in Drug Development Research Highlighting First-In-Class Preclinical Data of BAER-101 in a Translational Model of Absence Epilepsy
Friday 23 February 2024 (2 months ago) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Friday 2 February 2024 (3 months ago) • Edgar (US Regulatory)

Form DEF 14C - Other definitive information statements
Tuesday 30 January 2024 (3 months ago) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Thursday 25 January 2024 (3 months ago) • Edgar (US Regulatory)

More Avenue Therapeutics Inc News Articles

Gold vs US Dollar

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions